NDC 0641-6001 – Ativan
Lorazepam 2 mg/mL · Injection · Intramuscular, Intravenous
Product NDC0641-6001
Product details
- Brand name
- Ativan
- Generic name
- Lorazepam
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Dosage form
- Injection
- Route
- Intramuscular, Intravenous
- Marketing category
- NDA · NDA018140
- Marketed since
- July 25, 1980
- Listing expires
- December 31, 2027
- Pharmacologic class
- Benzodiazepine
Active ingredients
- Lorazepam 2 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0641-6001-25 | 25 VIAL in 1 CARTON (0641-6001-25) / 1 mL in 1 VIAL (0641-6001-01) | Jul 25, 1980 |
Recalls mentioning this NDC
- D-1308-2022 Aug 17, 2022 · Class II
Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.
Other Ativan products
- 0187-0063 Lorazepam .5 mg/1 · Tablet · Bausch Health US LLC
- 0187-0064 Lorazepam 1 mg/1 · Tablet · Bausch Health US LLC
- 0187-0065 Lorazepam 2 mg/1 · Tablet · Bausch Health US LLC
- 0641-6000 Lorazepam 2 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0641-6002 Lorazepam 4 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0641-6003 Lorazepam 4 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.